In a shocking turn of events, both the Indiana House and Senate have approved a bill to legalize the possession and use of cannabidiol (CBD) oil for those suffering from treatment resistant epilepsy in the Hoosier State.
Multiple medical cannabis bills have been introduced to the Indiana Legislature the past few years, but none have even received a hearing. This time though, the House passed the bill unanimously 95 to zero. In the same day, the Senate voted 35 to 13 in support.
Families with children suffering from severe forms of epilepsy, living in Indiana, have reportedly been pushing for this CBD-only law to be approved so that their children may have access to this treatment option. CBD is the non-psychoactive cannabinoid in cannabis that has received national recognition for reducing the duration as well as the total number of seizures suffered by children with epilepsy. Because it is non-psychoactive, CBD oil does not produce the high associated with full potency marijuana that contains higher percentages of THC.
Written by 42 representatives and sponsored by five more, House Bill 1148, would allow those suffering from ‘treatment resistant epilepsy’ to possess and use CBD oil if a state-approved physician recommends it. The department of heath would be responsible for keeping track of those registered as CBD oil patients.
Not signed into law yet, a committee is tasked with deciding what percentage of THC will be allowable, and then it will head to the governor’s desk for consideration.